Gianluca Fuggetta

CIK: 0001958188

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GANX

Gain Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

GANX
Gain Therapeutics, Inc.
Mar 24, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
50K shares-
GANX
Gain Therapeutics, Inc.
Mar 20, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
50K shares-

		Type	Shares	Price		Ownership
Mar 24, 2026	GANX Gain Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	50,000	-	-	Direct
Mar 20, 2025	GANX Gain Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	50,000	-	-	Direct

1-2 of 2 transactions

About Fuggetta Gianluca

Fuggetta Gianluca (SEC CIK 0001958188) files insider reports with the SEC as Officer of Gain Therapeutics, Inc. (GANX).

Signal8 holds 2 ownership filings by Fuggetta Gianluca, all Form 4s, filed between Mar 21, 2025 and Mar 26, 2026. Those filings report 2 transactions, from Mar 20, 2025 to Mar 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fuggetta Gianluca's filings is in BETHESDA, MD.

Recent filings by Fuggetta Gianluca

Mar 24, 2026: Grant or award of GANX derivative securities (Form 4, code A).
Mar 20, 2025: Grant or award of GANX derivative securities (Form 4, code A).

Other insiders filing for Gain Therapeutics, Inc. (GANX)

How to read Form 4 transaction codes